Moderna (MRNA)-Update

Moderna (MRNA)-Update
1 day
In: Moderna (MRNA), Health & Biotech

Moderna has surpassed our expectations and is displaying stronger bullish impulse than previously anticipated. If this plays out as expected, Moderna has built a massive bullish setup.

Our last Fibonacci retracement zone was not activated by the market. Moderna pushed too bullishly and therefore did not validate our bearish scenario. As a result, we have revised our primary outlook, which now looks significantly more bullish, pointing towards a long-term uptrend. To find an entry in this market, we have also defined a new Fibonacci retracement zone.

Long Entry Levels:

  • 50% at $64.72
  • 61.8% at $59.79
  • 78.6% at $52.77

Stop Loss: 1% below the zone at $52.24

This zone represents a perfect buying opportunity to get positioned before this stock begins pushing higher with rapid bullish momentum.

Should anything change with this stock, or once Moderna reaches and activates our newly defined Fibonacci zone, we will update you immediately.

Kind regards,
Monalytics

DISCLAIMER: The content on this website, including charts, analyses, and recommendations, is for informational purposes only and does not constitute financial, investment, or professional advice. Trading and investing involve risk. You should consult a qualified financial advisor before making any investment decisions.

More from MOnalytics
Great! You’ve successfully signed up.
Welcome back! You've successfully signed in.
You've successfully subscribed to MOnalytics.
Your link has expired.
Success! Check your email for magic link to sign-in.
Success! Your billing info has been updated.
Your billing was not updated.